
ePT--the Electronic Newsletter of Pharmaceutical Technology
Novo Nordisk Drops Inhaled Insulin Product, Neurocrine Appoints CEO and President, More...

ePT--the Electronic Newsletter of Pharmaceutical Technology
Novo Nordisk Drops Inhaled Insulin Product, Neurocrine Appoints CEO and President, More...

ePT--the Electronic Newsletter of Pharmaceutical Technology
Crucell and Sanofi Pasteur Sign Agreement, WuXi Pharma Names COO, More...

ePT--the Electronic Newsletter of Pharmaceutical Technology
Merck Sells Facility to Cherokee Pharmaceuticals, Inflazyme Announces Senior Management Resignations, More...

The authors propose extending initial solvent screening for a single-solvent system to the cocktail solvent screening of binary and ternary solvent mixtures.

FDA’s May 1999 container-closure guidance has accelerated the requirements for extractable and leachable testing of container-closure packaging components. Since that date, additional recommendations have been made by industry groups to clarify how these issues should be addressed.

Brief pharmaceutical news items for January 2008.

Editors' Picks of Pharmaceutical Science & Technology Innovations

As FDA implements new drug-safety policies, manufacturers will focus on quality and pricing.

Pharmaceutical Technology Europe
Historically, the main purpose of laboratory information management systems (LIMS) has been to track and manage samples in the laboratory. LIMS originated nearly 30 years ago as a rudimentary method of automating manual, error-prone processes in the laboratory and, with the growth in adoption of technology, became the de facto benchmark for laboratory control and management.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Millipore and Novozymes Form Alliance, Applied Biosystems Names President and CEO, More

ePT--the Electronic Newsletter of Pharmaceutical Technology
Merck & Co. initiated a voluntary recall of 11 lots of its Haemophilus influenzae type B vaccine, Pedvaxhib, and two lots of its combination Haemophilus influenzae type B/ hepatitis B vaccine, Comvax.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: West to reduce workforce, Eli Lilly's CEO and chairman to retire, more...

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Eisai Acquires MGI Pharma, Ceregene Names CEO, More

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Boehringer Ingelheim Expands Facility, Regulus Therapeutics Names President and CEO, More

Expansions

Various manufacturing techniques can improve a drug's solubility, thus increasing its bioavailability. The authors examined whether melt granulation can enhance drug solubility using meloxicam as the drug substance and myrj-52 as the binder.

In honor of Pharmaceutical Technology's 30th anniversary, the editors conducted a survey of 320 readers last spring to discuss industry advances and future directions. Here are some of your foward-looking responses.

Industry and regulatory organizations agree that the current focus on product quality will play a major role in shaping pharmaceutical development in the future. Key to this assessment of quality are the methods and technologies in pharmaceutical analytical testing.

How do you answer an inspector's questions? How do you validate analytical methods? One book has answers for compliance professionals.

"May you live in interesting times," goes the allegedly ancient Chinese curse. Well, these have been "interesting times" indeed for those working in the pharmaceutical industry.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: ISP to raise prices, Patheon appoints CEO, more.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Cambridge Major Labs acquires ChemShop; Helix BioPharma restructures senior positions, more.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: BASF raises prices on excipients; Verus Pharmaceuticals appoints president and CEO; more.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Submitting a safety update to European regulators, Novartis provided data showing its 100-mg once-daily dose of ?Galvus? (vidagliptin), an oral type 2 diabetes treatment, has more frequent liver enzyme elevations in patients than its already approved 50-mg once- and twice-daily doses.

ePT--the Electronic Newsletter of Pharmaceutical Technology
Pfizer's Lipitor patent revoked in Germany, promotions at Charles River Labs, more.